From intravenous to subcutaneous infliximab in patients with inflammatory bowel disease: a pandemic-driven initiative
- PMID: 33444534
- DOI: 10.1016/S2468-1253(20)30392-7
From intravenous to subcutaneous infliximab in patients with inflammatory bowel disease: a pandemic-driven initiative
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
